NDRG2 expression is significantly reduced or absent in many human tumor tissues, such as breast cancer, liver cancer, colorectal cancer, and malignant glioma, suggesting that NDRG2 has an inhibitory effect on tumorigenesis. Here, NDRG2 is linked to breast carcinoma.